𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A new locus-specific database (LSDB) for mutations in the TGFBR2 gene: UMD-TGFBR2

✍ Scribed by Melissa Yana Frederic; Dalil Hamroun; Laurence Faivre; Catherine Boileau; Guillaume Jondeau; Mireille Claustres; Christophe Béroud; Gwenaëlle Collod-Béroud

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
476 KB
Volume
29
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

Communicated by Alastair F. Brown

The implication of mutations in the TGFBR2 gene, known to be involved in cancers, in Marfan syndrome (MFS) and later in Loeys-Dietz syndrome (LDS) and Familial Thoracic Aortic Aneurysms and Dissections (TAAD2) gives a new example of the complexity of one gene involved in multiple diseases. To date, known TGFBR2 mutations are not disease-specific and many mutations have to be accumulated before genotype-phenotype relationships emerge. To facilitate mutational analysis of the TGFBR2 gene, a locus-specific database has been set up with the Universal Mutation Database (UMD) software. The version of the computerized database contains 85 entries. A total of 12 mutations are reported to be involved in MFS, six in incomplete MFS, 30 in LDS type I, 10 in LDS type II, seven in TAAD2, and 20 in various cancers. The database is accessible online at http:// www.umd.be (last accessed: 3

📜 SIMILAR VOLUMES

A new locus-specific database (LSDB) for
A new locus-specific database (LSDB) for mutations in the folliculin (FLCN) gene
✍ Derek H.K. Lim; Pauline K. Rehal; Michael S. Nahorski; Fiona Macdonald; Tijs Cla 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

Birt-Hogg-Dubé syndrome (BHD) is an autosomal dominant condition characterised by the presence of facial fibrofolliculomas, pulmonary cysts which may be associated with spontaneous pneumothorax and renal tumours. Germline mutations in the gene Folliculin (FLCN) were first identified in BHD patients

UMD-predictor, a new prediction tool for
UMD-predictor, a new prediction tool for nucleotide substitution pathogenicity—application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2
✍ Mélissa Yana Frédéric; Marine Lalande; Catherine Boileau; Dalil Hamroun; Mireill 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Approximately half of gene lesions responsible for human inherited diseases are due to an amino acid substitution, showing that this mutational mechanism plays a large role in diseases. Distinguishing neutral sequence variations from those responsible for the phenotype is of major interest in human

DYT6 dystonia: Review of the literature
DYT6 dystonia: Review of the literature and creation of the UMD locus-specific database (LSDB) for mutations in the THAP1 gene
✍ Arnaud Blanchard; Vuthy Ea; Agathe Roubertie; Mélanie Martin; Coline Coquart; Mi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

By family-based screening, first Fuchs and then many other authors showed that mutations in THAP1 (THAP [thanatos-associated protein] domain-containing, apoptosis-associated protein 1) account for a substantial proportion of familial, early-onset, nonfocal, primary dystonia cases (DYT6 dystonia). TH

UMD-DYSF, a novel locus specific databas
UMD-DYSF, a novel locus specific database for the compilation and interactive analysis of mutations in the dysferlin gene
✍ Gaelle Blandin; Christophe Beroud; Veronique Labelle; Karine Nguyen; Nicolas Wei 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Mutations in the dysferlin gene (DYSF) lead to a complete or partial absence of the dysferlin protein in skeletal muscles and are at the origin of dysferlinopathies, a heterogeneous group of rare autosomal recessive inherited neuromuscular disorders. As a step towards a better understanding of the D

Functional analysis of three splicing mu
Functional analysis of three splicing mutations identified in the PMM2 gene: Toward a new therapy for congenital disorder of glycosylation type Ia
✍ Ana I. Vega; Celia Pérez-Cerdá; Lourdes R. Desviat; Gert Matthijs; Magdalena Uga 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

The congenital disorders of glycosylation (CDG) are a group of diseases caused by genetic defects affecting N-glycosylation. The most prevalent form of CDG-type Ia-is caused by defects in the PMM2 gene. This work reports the study of two new nucleotide changes (c.256-1G>C and c.640-9T>G) identified